Trump’s planned crypto reserve pits Bitcoin loyalists against ‘alt-coin’ boosters
Cameron Winklevoss says “Bitcoin is the only asset that meets the bar for a store of value reserve asset.” Read...
Finance
After Trump-Zelensky blowup, Europe may be more willing to seize frozen Russian assets while EU official says ‘free world needs a new leader’
"Are the Europeans willing to stand up for themselves, for their principles, for their values, and for fellow Europeans? And...
Solana hits 5-month low as memecoin traders back off after $LIBRA scandal
Solana is often associated with memecoins because of its high transaction speed and low fees. Read More Source link...
Warren Buffett never considers where execs graduated from and says a ‘large portion’ of business talent is innate
“One further point in our CEO selections: I never look at where a candidate has gone to school. Never!” Read...
The downfall of AI startup Humane reveals the perils of the AI ‘race’
The startup created its wearable AI device with laudable ambition and out-of-the-box thinking, but it couldn't overcome key flaws. Read...
When Rupert Murdoch dies, James Murdoch says he may rein in Fox News
Fox has already paid $787 million to settle a defamation case after it broadcast unfounded allegations that the 2020 U.S....
56% of Gen Z homeowners have renovation plans for 2025, vs. just 32% of baby boomers
© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use...
The U.S. is battling its worst flu season in at least 28 years. Here are the latest symptoms and where cases are skyrocketing
If you’re feeling under the weather but brushing it off as just a cold, you might consider taking a flu...
Sony PlayStation Network outage enrages gamers around the world
“PSN down on a Friday night is criminal,” a London-based user named Ramos wrote on X. Read More Source link...
The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck
Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings. Read More Source link...
Powered By
